Philips has recommended that customers immediately stop using affected Tack endovascular systems and return unused product to ...

This recall involves removing devices from use and sale. According to the FDA notice, the device may cause serious injury of ...

Philips is pulling from the market an implant designed to help repair the interior of damaged blood vessels, following a serious product recall. | Philips is pulling from the market an implant ...

Data from two French registries suggested that the need for reintervention after transcatheter aortic valve replacement was ...

The FDA says user challenges and need for additional procedures drove recommendations to stop using the system immediately.

Medical device recalls surged last year, driven by stricter FDA oversight and a big jump in the most serious type of recalls.

The U.S. Food & Drug Administration said that Philips has removed and discontinued distribution of Tack Endovascular System ...

With its recent clearance in France, the Sleep & Respiratory Care business at Philips can once again sell products in all ...

Philips has posted 33.6% higher losses for 2024 compared to 2023 as the company continues to battle weaker demand in China and settlements for its faulty sleep apnoea devices. Philips reported ...

Philips ended 2024 deep in the red, suffering a loss of 698 million euros, the health tech company announced on Wednesday.

Philips (PHG) stock drops 11% as its Q4 revenue misses expectations due to China demand concerns and the company projects a ...